Teachers Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$4.66M Buy
347,939
+2,254
+0.7% +$25.7K 0.01% 1461
2018
Q4
$3.21M Buy
345,685
+7,089
+2% +$84.4K ﹤0.01% 1559
2018
Q3
$4.71M Sell
338,596
-514
-0.2% -$7.64K 0.01% 1485
2018
Q2
$5.36M Buy
339,110
+61,480
+22% +$1.07M 0.01% 1393
2018
Q1
$4.77M Buy
277,630
+5,927
+2% +$116K 0.01% 1358
2017
Q4
$5.96M Buy
271,703
+12,634
+5% +$406K 0.01% 1259
2017
Q3
$10.6M Buy
259,069
+1,058
+0.4% +$33.2K 0.01% 1002
2017
Q2
$7.77M Buy
258,011
+16,640
+7% +$519K 0.01% 1114
2017
Q1
$8.73M Buy
241,371
+2,943
+1% +$130K 0.01% 1044
2016
Q4
$11.9M Buy
238,428
+1,558
+0.7% +$81.9K 0.02% 874
2016
Q3
$12.4M Buy
236,870
+4,008
+2% +$191K 0.02% 837
2016
Q2
$9.63M Buy
232,862
+44,893
+24% +$1.95M 0.02% 889
2016
Q1
$7.64M Buy
187,969
+30,403
+19% +$1.04M 0.01% 974
2015
Q4
$6.54M Buy
157,566
+3,329
+2% +$112K 0.01% 1047
2015
Q3
$2.37M Hold
154,237
﹤0.01% 1466
2015
Q2
$3.83M Buy
154,237
+126,782
+462% +$2.82M 0.01% 1277
2015
Q1
$627K Buy
27,455
+3,468
+14% +$87.5K ﹤0.01% 2307
2014
Q4
$648K Hold
23,987
﹤0.01% 2291
2014
Q3
$281K Hold
23,987
﹤0.01% 2711
2014
Q2
$373K Buy
23,987
+9,327
+64% +$134K ﹤0.01% 2609
2014
Q1
$288K Buy
14,660
+9,110
+164% +$155K ﹤0.01% 2693
2013
Q4
$93K Buy
+5,550
New +$69K ﹤0.01% 3034

Other funds holding FPRX

Teachers Advisors's FPRX Position: Q1 2019 in Review

Teachers Advisors increased its Five Prime Therapeutics, Inc. (FPRX) stake by 0.65% in Q1 2019, buying an estimated $25.7K and bringing the position to 347,939 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #1461.

Teachers Advisors first reported a position in FPRX in Q4 2013 and has held it in 22 quarters since. The position peaked at $12.4M in Q3 2016. 113 funds tracked by Wall St. Rank hold FPRX as of Q1 2019.

  • Teachers Advisors held 347,939 shares of Five Prime Therapeutics, Inc. worth $4.66M as of Q1 2019.
  • Teachers Advisors bought 2,254 Five Prime Therapeutics, Inc. shares in Q1 2019, an estimated $25.7K.
  • Five Prime Therapeutics, Inc. made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1461 holding.
  • Teachers Advisors first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and has held it in 22 quarters since.
  • Teachers Advisors's Five Prime Therapeutics, Inc. position peaked at $12.4M in Q3 2016.
  • 113 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.